PS1148 PRELIMINARY RESULTS OF A PHASE 1B/2 DOSE-ESCALATION AND COHORT-EXPANSION STUDY OF THE NONCOVALENT, REVERSIBLE BRUTON'S TYROSINE KINASE INHIBITOR (BTKI), VECABRUTINIB, IN B-CELL MALIGNANCIES
2014 ◽
2015 ◽
Vol 1358
(1)
◽
pp. 82-94
◽
2013 ◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS7100-TPS7100
◽